Cited by 360Syphilis Diagnosis and TreatmentHistorical Medical Research and TreatmentsVector-borne infectious diseases

2014 European guideline on the management of syphilis

Janier, M., Hegyi, V., Dupin, N., Unemo, M., Tiplica, G.S., Potočnik, M., French, P., Patel, R.·2014·Journal of the European Academy of Dermatology and Venereology

Abstract

Background: Syphilis remains a major public health problem in Europe (both in Eastern Europe since the 1990's and in Western Europe since the re‐emergence of the disease in the late 1990's‐early 2000's). Methods: This guideline is an update of the IUSTI: 2008 European guideline on the management of syphilis and is produced by the European Guideline Editorial Board (http://www.iusti.org/regions/Europe/pdf/2013/Editorial_Board.pdf) and EDF Guideline Committee. Results: It provides recommendations concerning the diagnosis and management of syphilis in Europe. Major advances include (1) broader use of PCR, immunohistochemistry, subtyping of the etiological agent Treponema pallidum subspecies pallidum, new treponemal tests, and rapid‐point‐of‐care (POC) tests detecting both treponemal and non‐treponemal antibodies, (2) more flexible options for screening (TT‐treponemal test‐ first or NTT –non treponemal test‐ first or both TT and NTT), and (3) procaine penicillin is no longer the first line therapy option in any phase of the disease, i.e. long acting penicillin G (i.e. benzathine penicillin G‐BPG) is the only first line therapy regimen in early syphilis and in late latent syphilis. Conclusions: Syphilis is a disease that is relatively easy to detect by appropriate serological tests, however, all laboratory results should be considered together with clinical data and sexual risk anamnesis. Syphilis is also easy to treat with BPG. A major concern about the supply of BPG in many European countries could threaten the efficacy of the policies of eradication of the disease in Europe.

Integrity signals

Registry

Crossref · 10.1111/jdv.12734

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early detection of IgM could help with the diagnosis of early syphilis.

    “Early detection of IgM could, therefore, help with the diagnosis of early syphilis.”
  • The first class of immunoglobulin to respond after a recent infection is immunoglobulin (Ig) M.

    “The first class of immunoglobulin to respond after a recent infection is immunoglobulin (Ig) M.”
  • A positive IgM result may be useful if primary or congenital syphilis is suspected.

    “A positive IgM result may be useful if primary or congenital syphilis is suspected.”

    From BASHH UK guidelines for the management of syphilis 2024 (2024) · cites this paper as [49]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Janier, M., Hegyi, V., Dupin, N., Unemo, M., Tiplica, G. S., Potočnik, M., French, P., & Patel, R.
Affiliations
  • Hôpital Paris Saint-Joseph (FR)
  • Comenius University Bratislava (SK)
  • Hôpital Cochin (FR)
  • Örebro University Hospital (SE)
  • 2nd Dermatological Clinic Carol Davila University Colentina Clinical Hospital Bucharest Romania
  • Ljubljana University Medical Centre (SI)
  • Central and North West London NHS Foundation Trust (GB)
  • Royal South Hants Hospital (GB)
Corresponding author
Janier, M.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2014-10-27
Volume
28
Issue
12
Pages
1581-1593
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2160743838
Cited by
360
References
106
Citations by year
2026: 4 · 2025: 10 · 2024: 12 · 2023: 17 · 2022: 24 · 2021: 51 · 2020: 51 · 2019: 49 · 2018: 34 · 2017: 31 · 2016: 36 · 2015: 39 · 2014: 2
FWCI
23.93
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the European Academy of Dermatology and Venereology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Society of Clinical Microbiology and Infectious Diseases
  • European Academy of Dermatology and Venereology
Topics
  • Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Historical Medical Research and Treatments
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords
syphilis, Treponema pallidum subspecies pallidum, syphilis diagnosis, syphilis screening, PCR detection, immunohistochemistry, point-of-care testing, benzathine penicillin G, procaine penicillin, syphilis treatment, Europe
MeSH terms
Anti-Bacterial Agents, Europe, Humans, Penicillin G Benzathine, Syphilis, Treponema pallidum, Polymerase Chain Reaction, Practice Guidelines as Topic, Point-of-Care Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review